Author: OurCrowd

[Terra CO2 in AGGregates Business] A cost-competitive reach for the cement CO₂-busting stars

After securing significant investment in its innovative supplementary cementitious materials (SCMs) as alternatives to Portland cement and fly ash products, Terra CO2 recently began building its future commercial facilities. Aggregates Business America Editor GUY WOODFORD spoke to company CEO Bill Yearsley to learn more about the business’s impressive rise and next steps. Read...

Read More

[Ursa Major in Ursa Major] Ursa Major and partners launch the Alliance for the American Additive Manufacturing Ecosystem

BERTHOUD, Colo., July 24, 2025 — Ursa Major has announced the formation of the Alliance for the American Additive Manufacturing Ecosystem, known as AAAME, a multi-stakeholder initiative that unites leaders across the broad ecosystem of defense, manufacturing, and technology sectors to accelerate the adoption of additive manufacturing for national security. Other founding members include Dyndrite, EOS, and nLight. Read more...

Read More

[SaNOtize in The Globe and Mail] Scientists rethink personal hygiene: NOWONDER Nasal Spray is leading the charge

In a dramatic shift in the way Americans approach everyday hygiene, scientists are urging a renewed focus on nasal care as a central component of personal wellness, and one product is taking the lead. NOWONDER, the newly rebranded version of Enovid SaNOtize Nitric Oxide Nasal Spray (NONS), is rapidly gaining recognition as a revolutionary solution in modern personal protection. Read more...

Read More

[Scopio in PR Newswire] Scopio Labs unveils first-of-its-kind AI-powered solution to fully automate blood morphology

PARSIPPANY, N.J., July 24, 2025 /PRNewswire/ — Scopio Labs, developer of Full-Field Cell Morphology imaging and analysis platform, announced today the unveiling of its groundbreaking Complete Blood Morphology (CBM®) analyzer. CBM will bring unprecedented scale, efficiency and standardization to hematology through autonomous morphology analysis and reporting, one of the last remaining manual processes in diagnostics. To expedite the go-to-market of CBM®, Viola Growth has joined as a new investor with a $10 million extension to Scopio’s Series D funding, bringing the total to $52 million. Read more...

Read More

[ThetaRay in BusinessWire] ThetaRay launches self-service rule builder and simulator giving compliance teams direct control and ffaster rule deployment

NEW YORK–(BUSINESS WIRE)–ThetaRay, a leading provider of Cognitive AI financial crime compliance technology, today announced the launch of its Self-Service Rule Builder and Simulator, two powerful tools enhancing its transaction monitoring solution, enabling compliance teams to create, test, and optimize anti-money laundering (AML) rules faster, with full autonomy and control. Read more...

Read More